文章詳目資料

Annals of Nuclear Medicine and Molecular Imaging

  • 加入收藏
  • 下載文章
篇名 Comparison of Fluorine-18-Fluorodeoxyglucose PET with Technetium-99m-MDP Whole Body Scan in a Patient with Bone Metastases from Unknown Primary Cancer
卷期 13:3
並列篇名 氟-18-去氧葡萄糖正子造影和鎝-99-m-MDP骨閃爍造影在轉移性骨癌的應用比較:一病例報告
作者 孫盛生蔡世傳譚台笙高嘉鴻
頁次 185-188
關鍵字 氟-18-去氧葡萄糖全身正子造影鎝-99-m-MDP骨閃爍全身造影轉移性骨癌?F-FDG PET[fee6]Tc-MDP whole body scanBone metastases
出刊日期 200009

中文摘要

     本文主要報告一位有鎖骨病理性骨折的46歲男性病人,被安排一系列之檢查,包括電腦斷層掃描、腹部超音波等等,但臨床上卻找不到確定的原發性腫瘤,故進一步安排氟-18-去氧葡萄糖(FDG)的全身正子造影(PET)檢查來尋找原發性腫瘤以及評估全身轉移的情形。此病例再一次印證了PET在尋找原發性腫瘤及評估全身轉移上的高度價值。

英文摘要

     At present, metastatic bone disease is usually assessedusing technetium-99m-methylene diphosphonate (99mTc-MDP) whole body scan, which is a sensitive but nonspecific method for evaluation of osseous metabolism. Several studies have shown that fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDG PET) is a useful imaging tool for detection of bone metastases and differentiation of benign and malignant lesions. Another advantage of 18F-FDG PET is that all organ systems can be visualized and evaluated in a single whole-body imaging session. We present a case of a 46-year-old male patient with suspected bone metastases from unknown primary cancer who was placed in an oncology screening program that included 18F-FDG PET whole-body scan for primary tumor detection and staging.

相關文獻